Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Question? Why wouldn't a biotech such as Bayer just request to license cell in a box. If Bayer was truly interested wouldn't they first request a sample to test in their own trial and if it worked just do a license agreement. Why buy the company just to use their intellectual property. What am I missing.
Now that's the ticket!
Thinking we should charter a couple buses.
The difference sunspotter is that Cellceutix is NOT a scammy would-be-biopharmaceutical as your posts would elude too.
Leo may now enter into a B-ABSSSI phase3 big pharma partnership. Partnership would put Cellceutix pipeline on the map and boost share price to uplist. The value of Brillacidin as a new class antibiotic has only increased.
Exactly. Further validation reverses chart big time.
Millions of retail shares bought from .40 to .80 cents in July. Now profit taking coupled with some implied fear factor of stock selling off before next data sets. IMO stock price should shore itself due to the fact more news is imminent.
That other stock got you a little rattled.lol
I agree that it looks of collusion between the article writer(s) and Rosen. SA put the article out and the law firm sat back and watched the stock sell off. After two hours of stock dropping like a stone, Rosen law firm submitted their already written securities claims loss press release. All my opinion but it sure seems fishy that it all hit at once.
Not getting one darn share from me, too much upside potential.
In my opinion they are in cahoots.
Thank You for posting your visit.
Prurisol PR finally posted on yahoo.
http://finance.yahoo.com/news/cellceutix-commences-phase-2-trial-123000005.html
Wow what a beat down. Article was bordering on personal attack against Dr Menon. Would be nice to see the latest on the Kevetrin trial real soon.
What a great day for Anavex investors. Stocks in mega beast mode.
Great post. Expansion of trial sites is excellent news.
Your posts are predictable.
This stock has legs to run. Preliminary showed cognizant benefit from taking A-273. No reason why second set of test patients wouldn't receive same benefit as the first set. Next waiting on top line data outcome in September. First set of patients requested to stay on the medication. Take that as a great validation.
Good news to feed the flipper(s) maybe even on this board. Leo can't get us off the pinks soon enough.
Last years was sent out Sept 15.
Thanks for that great post Karen. I'm also hoping Leo gives an update to the Medical Devices trial. If we get some positive news this would be huge.
Sometimes we answer our own questions.
If I had to make that decision I would probably sell my doublewide.
Site is down for maintenance.imo This is a good sign that someone with credentials (Leo) is doing an update.
doh. Hopefully have an update from Leo before then and let this down turn be the last. Get them while you can
Trial is double blind with water as the placebo comparative. Shouldn't take long for caregiver/investigator to put two and two together..
PR May 26, Enrollment Begins in Cellceutix Phase 2 Trial of Brilacidin-OM. Dosage is 3xday for 7weeks. Eight weeks since enrollment began so with any luck first patient should be complete.
Sorry I didn't read your comparison post before posting mine. I like yours better Drano.
Well said. That's why I like to go back and look at jazz 5 to 8 year progression. Ctix has all that and then some.
I'm expecting great news tomorrow. Prurisol set to go.
Hopefully a fair amount of his minions are sage enough to hold.
Nice. Go AVXL.
A recent post was that he had heard from several chemist saying Kevetrin was a joke. I'm sure it's no joke to the patients being treated.
This has become a bear trap to new investors. Investors buy in on great news only to have the life sucked out of their investment buy manipulators. The pinks is clearly killing this good investment.
Nice. My 50's now looking pretty sweet.
I'm looking for it to go higher tomorrow, the good news is just getting out. Should see a good write up soon also. Just a hunch though.
Agree. Holding tight. Make em pay.
Buyers have dried up as we wait for corporate update. Should be a doozy.
This is huge news for both shareholders and AD suffers: Anavex Presents Positive Initial Phase 2a Study Data With ANAVEX 2-73 Showing Early Evidence of Improving Cognition in Patients With Alzheimer’s Disease at AAIC 2015
Come on corporate update, were at the cusp of going on the Nasdaq.